Assessing patient preference for two types of elastomeric infusion device.

Area of Science:

• Medical Devices
• Patient Adherence
• Cystic Fibrosis Management

Background:

• Home antibiotic therapy is common for cystic fibrosis (CF) patients.
• Patient acceptance of drug delivery devices impacts adherence to complex regimens.
• Limited data exists on patient preference within specific elastomeric infusion device classes.

Purpose of the Study:

• To compare patient preference between two elastomeric infusion devices: Baxter Intermate (hard-shelled) and Fresenius Kabi Eclipse (soft-shelled).
• To evaluate factors influencing patient choice in infusion device selection for CF patients.

Main Methods:

• A study involving 24 cystic fibrosis patients.
• Patients were presented with and evaluated both the Baxter Intermate and Fresenius Kabi Eclipse devices.
• Patient preference was recorded, along with reasons for preference.

Main Results:

• 83% of patients (20/24) preferred the soft-shelled Eclipse device.
• 17% of patients (4/24) had no preference between the two devices.
• The Eclipse device was rated significantly higher for comfort and discreetness.

Conclusions:

• Patient preference for elastomeric infusion devices, particularly the soft-shelled Eclipse, is substantial.
• Comfort and discreetness are key factors driving patient preference.
• Incorporating patient preference into device selection can enhance concordance with antibiotic therapy regimens in cystic fibrosis care.